Stay updated on Daratumumab Combo in MRD+ Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Combo in MRD+ Myeloma Clinical Trial page.

Latest updates to the Daratumumab Combo in MRD+ Myeloma Clinical Trial page
- CheckyesterdayChange DetectedA notice announces an NIH-wide terminology transition, stating that agencies are using “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check8 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1; the page continues to show a 403 error.SummaryDifference0.2%

- Check15 days agoChange DetectedThe site footer’s revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check36 days agoChange DetectedRevision: v3.7.0 is displayed on the page, indicating a site version update. Several study document entries in the Study Documents section were removed, reducing access to materials such as the protocol and related plans.SummaryDifference18%

- Check57 days agoChange DetectedA new page revision label (v3.6.6) indicates an update to the page metadata. The related topics section was shortened by removing several topics and the older revision reference (v3.6.5).SummaryDifference0.1%

- Check64 days agoChange DetectedThe page now includes 'Multiple myeloma' as a topic and adds a 'related topics' entry for 'MedlinePlus Genetics'. This broadens the disease context and links to external resources without altering the study details.SummaryDifference0.1%

Stay in the know with updates to Daratumumab Combo in MRD+ Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo in MRD+ Myeloma Clinical Trial page.